Bindu Akkanti, M.D.

 

Associate Professor and Graham Distinguished Professorship in Pulmonary Medicine
Medical Director, Heart Failure ICU, Heart & Vascular Institute
McGovern Medical School
UTHealth Houston

Email: bindu.h.akkanti@uth.tmc.edu
Phone:  713-500-6875

Biography

Dr. Akkanti joined UTHealth in 2013 and is currently an Associate Professor in the Department of Medicine. She is a graduate of the University of Texas Southwestern Medical School. She completed her internship in Internal Medicine at Baylor College of Medicine and pursued a residency at Boston University Medical Center. She completed her fellowship in Pulmonary and Critical Care Medicine at Baylor College of Medicine and was trained in the areas of critical care, lung cancer, asthma, COPD, pulmonary hypertension, cystic fibrosis, lung transplantation, and other advanced lung diseases while on rotations at Ben Taub General Hospital, The Methodist Hospital, St. Luke’s Hospital, and the Michael E. DeBakey Veterans Affairs Medical Center. Dr. Akkanti later joined the Clinical Scientist Training Program and pursued bioinformatics based translational research in lung cancer under the guidance of Dr. Francesco DeMayo in the Department of Molecular and Cellular Biology at Baylor College of Medicine. She is also the founder of the Pulmonary Rehabilitation program in the Wellness Center at Memorial Hermann – TMC. Dr. Akkanti is married to Dr. Garg, an Associate Professor in Radiology at M.D. Anderson Cancer Research Center. She enjoys traveling, dancing and photography.

Areas of Interest

Clinical Interests:

Advanced lung diseases
Interstitial lung disease
Asthma
Pulmonary vascular diseases
Preoperative lung transplant evaluation
Postoperative lung transplant care
Pulmonary rehabilitation (including multidisciplinary supervised rehab)

Research:

Implications of pulmonary hypertension and mechanical circulatory support on patient outcomes.

  1. VENT-AVOID – Hemolung use in advanced COPD.  Click here for trial information.
  2. Leronlimab in COVID-19 – Phase 2/3 trial.  Click here for trial information.
  3. CSL-312, Phase 2 in COVID-19.  Click here for trial information.
  4. LOFT-HF.  Impact of low flow nocturnal oxygen therapy in patients with heart failure. Click here for trial information.

Education

  • Medical Degree
    UT Southwestern Medical Center, Dallas, TX
  • Residency
    Boston University Medical Center
  • Fellowship
    Baylor College of Medicine, Houston, TX

Board Certifications

American Board of Internal Medicine – Internal Medicine
American Board of Internal Medicine – Pulmonary Disease
American Board of Internal Medicine – Critical Care Medicine
American Society of Quality – Certified Manager of Quality

Publications

https://pubmed.ncbi.nlm.nih.gov/?term=akkanti